top-left-banner

Friday, Oct 31st

Last update09:16:01 AM GMT

TwitterLinkedinYoutubeGoogleFeed

Banner

User1

User2c

User3

You are here: News BioMedTech

Cambridge tech at heart of £53m dementia research platform

Cambridge Cognition CEO Nick KertonCutting edge technology from Cambridge Cognition and other Cambridge enterprises is playing a significant role in The Medical Research Council’s £53 million Dementias Research Platform UK (DPUK).

New CEO as Cambridge Epigenetix raises $5.5m

Professor Shankar Balasubramanian of the University of Cambridge’s Department of Chemistry Cambridge Epigenetix, a UK life sciences business, has appointed Dr Fedja Bobanovic as CEO and completed a $5.5M Series A financing led by New Science Ventures.

Babraham signals greater engagement with industry

Katy-Evans-RobertsThe Babraham Institute in the Cambridge UK technology cluster is hosting a science showcase event focusing on its signalling research programme, which aims to encourage academic-industrial collaborations.

AZ lines up second Cambridge blockbuster drug

Steve-JacksonCambridge is getting closer to giving the world a second blockbuster drug – almost a decade after giving birth to the UK’s first.

Global injector drug deal for Consort Medical

Jonathan-GlennConsort Medical company Bespak has won a significant development contract with a major global player for its autoinjector technology for drug delivery.

Cambridge drug hope for lethal child epilepsy

GW Pharmaceuticals CEO Justin GoverGW Pharmaceuticals in Cambridge has won a key European approval for a cannabis-based drug to fight Dravet’s syndrome – a rare and lethal form of childhood epilepsy resistant to current treatments.

Freewheeling Bicycle Therapeutics raises $32 million

Bicycle Therapeutics Chairman Andrew SandhamBicycle Therapeutics has raised £20 million ($32m) equity financing for  the clinical development of therapeutic bicycle drug candidates in oncology.

Cambridge-Sydney alliance seeks drugs to fight killer bugs

Eddy Littler, the Domainex CEODomainex in Cambridge and Auspherix Pty in Sydney have joined forces to develop new drugs to treat antibiotic-resistant bacterial infections.

Horizon wins $450k deal with top 10 Pharma business

Horizon Discovery CEO Dr Darrin DisleyUK personalised medicines enabler Horizon Discovery Group has clinched another big money deal with a top 10 pharmaceutical business working to beat cancer.

BioSilta and Sigma-Aldrich in cell culture alliance

Bob Penney, CEO at BioSiltaBioSilta Ltd, based in Cambridge UK, has tied up with Nasdaq-quoted power player Sigma-Aldrich to commercialise crucial technology for scientific researchers.

Sphere Medical praised for patient care advance

Dr Wolfgang Rencken, CEO of Sphere MedicalA new bedside blood test using Cambridge UK technology has been lauded following successful clinical trials with patients at the Queen Elizabeth Hospital, Birmingham.

Tristel stock tipped to go higher

Paul-Swinney-TristelFull-year results ahead of market expectations failed to boost Cambridge UK medical technology company Tristel’s early morning share price – it actually fell 1p to 73.50 at one stage.

DIY doctor technology hits home

Flow-Health-HubInstruments that can help patients become their own clinicians – and in their own home – have been made possible by technology from Cambridge Consultants.

Vectura inhaler IP clinches €1.5m

Chris-Blackwell-2014Cambridge UK medical technology business Vectura Group plc has earned a milestone payment of €1.5 million following marketing clearance for novel inhaler technology in Portugal.

BioBeat14 disrupts biotech status quo

Miranda-Weston-SmithBiotechnology has shaken up the business environment, creating new ways of thinking and a model for open innovation that is being adopted by other industries, according to Miranda Weston-Smith speaking ahead of a gamechanging event in the Cambridge UK life science and technology cluster.

Drug busting tech wins £3m US-UK cash

Dr Jerry Walker, CEO of Intelligent FingerprintingAn investment of £2.98m has been raised by Intelligent Fingerprinting, a Norwich company developing ground-breaking technology that detects drug use through fingerprint sweat analysis.

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »

Page 1 of 65